Experiment 821393
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | DIMERY,IW: LEGHA,S: GOEPFERT,H:. (1984). PHASE II TRIAL OF HOMOHARRINGTONINE (HHT) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN).. () |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS A PHASE II TRIAL WITH 8 PATIENTS WITH SQUAMOUS CELL CANCER OF THE HEAD AND NECK,THERE WAS ONE PARTIAL REMISSIONS,5 WHO PROGRESSED,1 WHO COULD NOT TOLERAATE THE DRUG AND 1 WHO HAS NOT BEEN EVALUATED YET. MYELOSUPPRESSION IS CUMULATIVE,BUT TOXICITY IN GENERAL IS TOLERABLE. |
| Dose amount | 4.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |